PHARMACEUTICALS: Provides for prescription drug pricing. (1/1/27) (EG SG EX See Note)

SB 369 requires Louisiana's state insurance plans (like Medicaid or Group Benefits) to pay pharmaceutical manufacturers no more than Medicare's price for covered drugs. It also prohibits insurers and pharmacy benefit managers from reimbursing less than Medicare's price for any brand-name, biosimilar, or generic drug. This sets Medicare's price as both a maximum for state plan purchases and a minimum for reimbursement, directly affecting drug manufacturers, insurers, and pharmacies serving Louisiana's state health programs. The bill takes effect January 1, 2027, and authorizes the state insurance commissioner to enforce these rules.